Testing as an Alternative to Quarantining: Key Considerations and Best Practices for Implementing Test to Stay

Mark McClellan, MD, PhD, is a physician-economist who focuses on quality and value in health care, including payment and coverage reform, real-world evidence, more effective policies to support drug and device innovation, and initiatives to increase the impact of health care, public health, and social service programs on population health. His work on responding to the COVID-19 public health emergency spanned virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines, including a COVID-19 response roadmap. He is former commissioner of the U.S. Food and Drug Administration, and former administrator of the Centers for Medicare & Medicaid Services, where he developed and implemented major reforms in health policy. He has also served as a member of the President’s Council of Economic Advisors and as a Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously Associate Professor of Economics with tenure at Stanford University.  Dr. McClellan is an independent board member on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; chairs the National Academy of Medicine’s Leadership Consortium for a Value and Science-Driven Health System; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Blackstone Life Sciences, Arsenal Capital Partners, and MITRE.

Andrea Thoumi, MPP, MSc is a population health scientist dedicated to improving Latine health equity. As a bilingual and bicultural researcher, her work aims to reduce health inequities by generating community-engaged evidence to change policy and clinical practice while centering community perspectives in research and scholarship. Her research sits in the intersection of cancer disparities, access to care, and health equity.

Ms. Thoumi brings over 15 year’s experience leading multi-national, multi-year projects with prior experience with PwC, the Brookings Institution, and the Duke-Margolis Institute for Health Policy.  Her subject matter expertise is in community health, health policy, health equity, and health financing. She has served as a senior advisor or project lead on research related to increasing cervical cancer screening in low-resource settings, strengthening COVID-19 testing and vaccination strategies, and identifying policies to support community health worker programs in the US.  

She was a BRIDGE Scholar (2024) and recipient of the Honorable Mention, Alice S. Hersh Emerging Leader Award, AcademyHealth (2023); Early-Stage Distinguished Investigator Award, Health Disparities Interest Group, AcademyHealth (2021); and Duke Presidential Award (2021) for her work with LATIN-19. Currently, she serves as Chair, Health Equity Interest Group and Student Representative, Board of Directors of AcademyHealth. Her work has been published in leading journals including Health Affairs, The Milbank Quarterly, AJPH, the Lancet, and Health Equity.

Ms. Thoumi holds a Master in Public Policy from Georgetown University, an MSc in Health Policy, Planning and Financing from the London School of Economics and the London School of Hygiene and Tropical Medicine, and BA in Community Health and International Relations from Tufts University. Currently, she is pursuing her doctoral degree in the Department of Population Health Sciences (DPHS), Duke University School of Medicine and is a graduate student researcher with the Research to Eliminate Global Cancer Disparities (REGAL) team.